Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / RIGHT 09/16/2030
-
Total 13F shares
-
31,673,425
-
Share change
-
+30,994,825
-
Total reported value
-
$4,419,543
-
Price per share
-
$0.14
-
Number of holders
-
46
-
Value change
-
+$4,324,539
-
Number of buys
-
44
Institutional Holders of Drugs Made In America Acquisition II Corp. - RIGHT 09/16/2030 (DMIIR) as of Q4 2025
As of 31 Dec 2025,
Drugs Made In America Acquisition II Corp. - RIGHT 09/16/2030 (DMIIR) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,673,425 shares.
The largest 10 holders included
Magnetar Financial LLC, First Trust Capital Management L.P., Hudson Bay Capital Management LP, Glazer Capital, LLC, TORONTO DOMINION BANK, MILLENNIUM MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Polar Asset Management Partners Inc., HGC Investment Management Inc., and AQR Arbitrage LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.